INACTIVATED MYCOBACTERIA FOR ORAL USE IN THE PREVENTION OF TUBERCULOSIS
The invention relates to inactivated mycobacteria for oral use in the prevention of tuberculosis, which are administered using a multi-dose regimen and with a reduced time interval between doses, such as to induce a tolerance-building to infection by the tubercle bacillus. The inactivated bacteria c...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
21.04.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention relates to inactivated mycobacteria for oral use in the prevention of tuberculosis, which are administered using a multi-dose regimen and with a reduced time interval between doses, such as to induce a tolerance-building to infection by the tubercle bacillus. The inactivated bacteria can be used with the aforementioned regimen to control the progression of the infection from a latent state to active tuberculosis.
Dans la présente invention, les mycobactéries inactivées destinées à être utilisées pour une administration par voie orale dans la prévention de la tuberculose suivant un schéma d'administration à doses multiples, sont administrées à un intervalle de temps réduit entre lesdites doses, de manière à induire une réponse "tolérante" face à l'infection par le bacille de la tuberculose. L'utilisation des bactéries inactivées selon ledit schéma d'administration permet de réguler la progression de l'infection depuis un état latent jusqu'à un état de tuberculose active. |
---|---|
AbstractList | The invention relates to inactivated mycobacteria for oral use in the prevention of tuberculosis, which are administered using a multi-dose regimen and with a reduced time interval between doses, such as to induce a tolerance-building to infection by the tubercle bacillus. The inactivated bacteria can be used with the aforementioned regimen to control the progression of the infection from a latent state to active tuberculosis.
Dans la présente invention, les mycobactéries inactivées destinées à être utilisées pour une administration par voie orale dans la prévention de la tuberculose suivant un schéma d'administration à doses multiples, sont administrées à un intervalle de temps réduit entre lesdites doses, de manière à induire une réponse "tolérante" face à l'infection par le bacille de la tuberculose. L'utilisation des bactéries inactivées selon ledit schéma d'administration permet de réguler la progression de l'infection depuis un état latent jusqu'à un état de tuberculose active. |
Author | MARZO ESCARTIN, ELENA CARDONA IGLESIAS, PERE-JOAN VILAPLANA MASSAGUER, CRISTINA |
Author_xml | – fullname: MARZO ESCARTIN, ELENA – fullname: CARDONA IGLESIAS, PERE-JOAN – fullname: VILAPLANA MASSAGUER, CRISTINA |
BookMark | eNrjYmDJy89L5WRw9_RzdA7xDHMMcXVR8I109ncCcl2DPB0V3PyDFPyDHH0UQoNdFTz9FEI8XBUCglzDXP1CPP39FPzdFEJCnVyDnEN9_IM9g3kYWNMSc4pTeaE0N4O8m2uIs4duakF-fGpxQWJyal5qSbyzo5GFuZmpkbmzMWEVAE2bLZg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | MYCOBACTERIES INACTIVEES DESTINEES A ETRE UTILISEES POUR UNE ADMINISTRATION PAR VOIE ORALE DANS LA PREVENTION DE LA TUBERCULOSE |
ExternalDocumentID | CA2876527C |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2876527C3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:48:54 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2876527C3 |
Notes | Application Number: CA20132876527 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200421&DB=EPODOC&CC=CA&NR=2876527C |
ParticipantIDs | epo_espacenet_CA2876527C |
PublicationCentury | 2000 |
PublicationDate | 20200421 |
PublicationDateYYYYMMDD | 2020-04-21 |
PublicationDate_xml | – month: 04 year: 2020 text: 20200421 day: 21 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | FUNDACIO INSTITUT PER A LA INVESTIGACIO EN CIENCIES DE LA SALUT "GERMANS TRIAS I PUJOL" (IGTP) CIBER DE ENFERMEDADES RESPIRATORIAS (CIBERES) |
RelatedCompanies_xml | – name: FUNDACIO INSTITUT PER A LA INVESTIGACIO EN CIENCIES DE LA SALUT "GERMANS TRIAS I PUJOL" (IGTP) – name: CIBER DE ENFERMEDADES RESPIRATORIAS (CIBERES) |
Score | 3.2605474 |
Snippet | The invention relates to inactivated mycobacteria for oral use in the prevention of tuberculosis, which are administered using a multi-dose regimen and with a... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | INACTIVATED MYCOBACTERIA FOR ORAL USE IN THE PREVENTION OF TUBERCULOSIS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200421&DB=EPODOC&locale=&CC=CA&NR=2876527C |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8IwFH9BNOpNUYPfPZjdiFlxZTssZus6mWEbgY3gidBtRC-DyIz_vq8LqBdu_Uhe2te819_v9bUFeEC8xvKFaXTmhkSCYixYx8xxQbJClyxjFkJUFdAPI9ZPn16nxrQB79u7MPU7od_144hoURnae1X769VfEMurcyvXj_IDm5bPfmJ72oYdqyWnuua5thjGXsw1zm3uaNHIRmLADNrje7CPILqnbEFMXHUnZfV_Q_FP4GCIssrqFBpF2YIjvv13rQWH4ea4G4sby1ufwUsQqXyPiYOehoRvPHaxiiTMIUjjSDxyBiQdCxJEJOkLgnqdiEhFn0jskyR1xYing3gcjM_h3hcJ73dwRLPfyc-4sx169wKa5bIs2kAyQzdzyjJJLUT4BUXQKeddneWWReemlJfQ3iXlanfXNRwrFaqzEqrfQLP6_Cpuccut5F2trR_m3394 |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8JAEJ4gGvGmqMEnezC9EdNCl_bQmHbb2mofBFqCJ8K2JXopRGr8-842oF647SOZ7M5mZr9vdnYX4AHxGs2XmtpbqBwJirqkPS3HBckKmdOM6ghRRUA_jKiXDl5m6qwB77u7MPU7od_144hoURnae1X76_VfEMuucys3j_wDm1ZPbmLY0pYdiyVXZMm2DGcU2zGTGDOYKUVjA4kBVZUhO4BDBNhDYQvO1BJ3Utb_NxT3FI5GKKuszqBRlG1osd2_a204DrfH3VjcWt7mHJ79SOR7TE30NCR8Y7GFVSRhJkEaR-KxGZB04hA_IonnENTr1IlE9InELklSyxmzNIgn_uQCuq6TMK-HI5r_Tn7OzN3Q-5fQLFdl0QGSqbKWKzTjio4Iv1AQdPJFX6a5risLjfMr6OyTcr2_qwstLwmDeeBHrzdwItQpzk0U-Raa1edXcYfbb8Xva839AA1Qgms |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INACTIVATED+MYCOBACTERIA+FOR+ORAL+USE+IN+THE+PREVENTION+OF+TUBERCULOSIS&rft.inventor=MARZO+ESCARTIN%2C+ELENA&rft.inventor=CARDONA+IGLESIAS%2C+PERE-JOAN&rft.inventor=VILAPLANA+MASSAGUER%2C+CRISTINA&rft.date=2020-04-21&rft.externalDBID=C&rft.externalDocID=CA2876527C |